Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Care Bare Rx vs Wisp

Care Bare Rx
Graded #60

Higher grade

vs+10.6
Wisp
Graded #262

Lower grade

The verdict

Care Bare Rx takes it — 75/100 to 64.4/100.

Care Bare Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oral as well as injectable routes for both molecules plus a brand Ozempic lane, bundled with hair, TRT and sexual health.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCare Bare Rx +18
68
50
Dose & formulationCare Bare Rx +18
94
76
Clinical oversightWisp +8
74
82
Labs & monitoringCare Bare Rx +9
62
53
FulfillmentCare Bare Rx +12
78
66
Contract termsCare Bare Rx +17
72
55
Care Bare Rx · left barWisp · right bar

The numbers

MetricCare Bare RxWisp
WeighScore75/10064.4/100
GradeCC
Scorecard rank#60#262
SemaglutideFrom $199/mo (shared weight-loss price)$225/mo (compounded oral)
TirzepatideFrom $199/mo (shared weight-loss price)Not disclosed
CoverageMulti-stateCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Care Bare Rx

Graded #60 · C

Strengths

  • Oral tirzepatide as well as injectable — rare in this ranking
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where it loses points

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated cost cannot be modeled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
Wisp

Graded #262 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Another provider to compare: CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard